The value of Syndromic testing to patient care

In this video, Dr Kay Roy addresses the value syndromic testing holds for patient care, analysing its benefits in the context of respiratory infections. Respiratory infections can be caused by viral and/or bacterial pathogens; syndromic testing panels exist for both viral and bacterial targets, as well as AMR gene targets which can be useful in assessing antimicrobial susceptibility and guiding treatment decisions.

Today, increasing focus is being placed on the importance of viruses in causing disease. Additionally, it is important to consider the impact of co-infection of viruses and bacteria, and their interactions, on management — especially in patient populations undergoing immunotherapy and hosting different organisms.

Syndromic testing adds value in the form of quick, reliable tests resulting in: a reduction of the number of tests needed, directed antibiotic and antiviral therapy, improved use of hospital facilities, a reduction in unnecessary hospital stays, and the stress this places on healthcare systems. For the patient, this results in improved care.

The reference cited in the video has been provided as a link in the see also section.